Events for December 2023

Asbestos litigation remains a dynamic and pivotal facet of the legal realm, holding profound consequences for both victims and implicated industries. In this enlightening session, we will unravel the intricate factors that shape legal proceedings involving asbestos. Our panel of experts will delve into crucial subjects, encompassing recent advancements in diagnosing and treating asbestos-related diseases, navigating the complexities of jurisdictional challenges within asbestos cases, and elucidating the strategic approaches employed by plaintiff firms to construct formidable cases. Furthermore, we will scrutinize contemporary trends within asbestos litigation, dissecting the legal intricacies and regulations that exert influence on this legal domain.

Preparing for a trial involves determining how to leverage documents. Strategizing a compelling narrative not only simplifies complex legal arguments but also leaves a lasting impression that can sway decisions in your client’s favor. Hence, at the early stages of any case, establishing a trial preparation strategy is crucial and should start taking shape during document review.

The pharmaceutical labeling carve-out regulations remain a source of complexity in several cases. The Hatch-Waxman Act created a way for the Food and Drug Administration (FDA) to approve generic drugs even if they omit information about protected use to encourage competition among generic products. However, following the Teva v. GSK ruling, businesses must exercise caution and recognize the intricate relationship between Orange Book listed use patents, reference listed drug's prescribing information, and promotional labeling and other related activities. Furthermore, as other skinny-labeling-related cases continue to emerge which emphasize the need for legal professionals, businesses and other practitioners to remain up-to-date [...]